SCHEDULE 14A

                                 (Rule 14a-101)

                     INFORMATION REQUIRED IN PROXY STATEMENT

                            SCHEDULE 14A INFORMATION

           Proxy Statement Pursuant to Section 14(a) of the Securities

                      Exchange Act of 1934 (Amendment No. )

Filed by the Registrant [x]
Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[ ] Preliminary Proxy Statement
[ ]  Confidential, for Use of the Commission Only (as permitted by Rule
     14a-6(e)(2))
[ ]  Definitive Proxy Statement
[ X ]  Definitive Additional Materials
[  ]  Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12

                        ProMedCo Management Company

                    (Name of Registrant as Specified in its Charter)

                        ProMedCo Management Company

                       (Name of Person(s) Filing Proxy Statement)

Payment of Filing Fee (check appropriate box):

[X]  No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-11(c) or Rule 14a-12.

     1) Title of each class of securities to which transaction applies:

     2) Aggregate number of securities to which transaction applies:

     3) Per unit  price  or  other  underlying  value  of  transaction  computed
        pursuant  to  Exchange  Act Rule 0-11 (Set forth the amount on which the
        filing fee is calculated and state how it was determined):

     4) Proposed maximum aggregate value of transaction:

     5) Total feed paid:

[ ] Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange  Act Rule
0-11(a)(2)  and  identify  the  filing  for  which the  offsetting  fee was paid
previously.  Identify the previous filing by registration  statement  number, or
the Form or Schedule and the date of its filing.

     1) Amount Previously Paid:
     2) Form, Schedule or Registration Statement No.:
     3) Filing Party:
     4) Date Filed:







FOR IMMEDIATE RELEASE

Contact: H. Wayne Posey

                  President and Chief Executive Officer
                     or

                  Robert D. Smith

                  Senior Vice President and Chief Financial Officer

                  817-335-5035

                 PROMEDCO IN CONTINUING DISCUSSIONS TO FINALIZE

                            GOLDMAN SACHS TRANSACTION

         FORT  WORTH,  Texas  (April 10,  2000) -- ProMedCo  Management  Company
(Nasdaq/NM:PMCO)  today announced a further  adjournment,  to Monday,  April 17,
2000, of its special  meeting to obtain  shareholder  approval of the previously
announced  issuance  of  $55  million  of the  Company's  Series  A  Convertible
Preferred  Stock to  affiliates  of Goldman  Sachs & Co. As a result of what the
Company believes are unfavorable market conditions for financing  throughout the
healthcare  services sector, the Company to date has obtained commitment letters
for $25 million of the $65 million of senior debt financing  contemplated by its
securities  purchase  agreement with Goldman  Sachs.  The purpose of this second
adjournment is to provide the opportunity for continuing discussions between the
parties in light of this development.

         The Company  believes that the combined $80 million of additional  debt
and equity financing available if the transaction is closed at this time will be
sufficient to implement its currently planned expansion program at least through
the end of 2001. The Company would continue to seek additional financing to fund
its continuing growth strategy thereafter.  ProMedCo is currently in discussions
with Goldman  Sachs  seeking its waiver of the  debt-financing  condition of the
agreement.

         This press release contains "forward-looking statements" which are made
pursuant to the safe harbor  provisions  of the  Private  Securities  Litigation
Reform  Act of  1995.  The  forward-looking  statements  are  based  on  current
expectations   and  may  be   significantly   impacted  by  certain   risks  and
uncertainties  described  herein and in the Company's Annual Report on Form 10-K
filed with the  Securities  and Exchange  Commission for the year ended December
31, 1998.  There can be no assurance that  statements made in this press release
relating to future events will be achieved.

         ProMedCo,  headquartered  in Fort Worth,  Texas, is a medical  services
company  that  coordinates  and  manages  the  delivery  of a  wide  variety  of
healthcare  services in  non-urban  communities.  ProMedCo  believes  that these
non-urban  communities,  which have  fewer  healthcare  providers  and lower HMO
penetration than urban areas,  offer an opportunity for the Company to capture a
substantial  portion of local healthcare  revenues.  By affiliating with leading
medical groups, the Company establishes a platform from which it can consolidate
the delivery of local healthcare  services.  ProMedCo then expands this platform
by  adding  ancillary  services,   physicians  and  mid-level  providers,   thus
increasing its share of local healthcare revenues.

                                       -END-